Tag: <span>Ontario</span>

Home / Ontario
Post

Interchangeability of COVID-19 vaccines

As per the Ministry of Health’s guidance on the Administration of the AstraZeneca COVID-19/COVISHIELD vaccine, individuals who have received one dose of the AstraZeneca/COVIDSHIELD vaccine, should receive a second dose of the AstraZeneca/COVISHIELD vaccine to complete their vaccination series.  HMC

Post

Pregnancy added to Highest Risk conditions for COVID-19 vaccine

In response to emerging data on the increased risk of severe illness for pregnant individuals, Ontario’s Vaccine Clinical Advisory Group (VCAG) has recommended the inclusion of pregnant individuals in the Highest Risk category of health conditions.  As part of this group, pregnant individuals and one primary caregiver are now eligible to receive their COVID-19 vaccines...

Post

Age eligibility for AstraZeneca COVID-19 vaccine expanded to 40+

The province of Ontario has announced that starting Tuesday, April 20, the AstraZeneca COVID-19 vaccine will be offered to individuals aged 40 and over at pharmacies across the province. Eligible individuals can book an appointment at participating pharmacies by accessing: https://covid-19.ontario.ca/vaccine-locations   Based on the review of data from Europe and the United Kingdom, Health Canada...

Post

COVID-19 Vaccination of the Senior 75+ Population 

• As of March 22nd, Peel residents aged 75 and older (including those who will turn 75 in 2021) are eligible to get vaccinated for COVID-19. These residents are currently being invited to book appointments at Peel Public Health clinics as well as hospital clinic sites. To access appointment booking for any of these sites, eligible...

Post

Extension of Second Dose Intervals for COVID- 19 Vaccines

Ontario government is extending the vaccination dose interval up to 16 weeks for the three two-dose vaccines currently approved by Health Canada (Pfizer-BioNTech, Moderna and AstraZeneca/COVISHIELD). This is based on the recommendation of the National Advisory Committee on Immunization (NACI). Individuals who have already booked their second dose will have their appointments rescheduled. This will...

Post

Astra Zeneca and blood clot risk in Europe

Health Canada has issued the following advisory statement “ Health Canada is aware of reports of adverse events in Europe following immunization with the AstraZeneca COVID-19 vaccine, and would like to reassure Canadians that the benefits of the vaccine continue to outweigh its risks. Health Canada authorized the vaccine based on a thorough, independent review...

Post

Janssen (Johnson and Johnson) COVID-19 Vaccine

On March 5, 2021, Health Canada authorized the use of the Janssen (Johnson and Johnson) vaccine. This vaccine is an adenovirus vector vaccine administered through a single dose. More information about the Janssen vaccine including how it works, how it’s given and possible side effects is available at https://www.canada.ca/en/health- canada/services/drugs-health-products/covid19- industry/drugs-vaccines- treatments/vaccines/janssen.html HMC

Post

More COVID-19 Vaccine Info

 Dear Patients,  As you all know, the first vaccines are being given to higher risk people and health care workers. But we look forward to when we will have access to the vaccine. We do not yet know the place or the timing and we will communicate this when we do.  Some questions have arisen that...

Post

COVID-19 Vaccines

Dear community members and families, In the last few weeks, we have seen significant movement in our understanding of the COVID-19 vaccines. As of today, here is what we know: The vaccines are safe The vaccines approved for use in Canada work by sending a message to our body’s immune system to stimulate our natural immune response....

Post

COVID-19

The first two cases in Peel Region were tested positive on March 4th who were a couple aboard Grand Princess Cruise Ship from February 11- 21 out of San Fransisco. Both are recovering at home in self-isolation. The risk to the public remains low. There is no evidence that COVID-19 is circulating in the community....

Post

Update on 2019-nCoV

Canada has had 4 and Ontario 3 confirmed cases as of Feb 3, 2020. This are 29 cases under investigation in Ontario. There were no cases in Peel Region. Worldwide, 17485 confirmed cases and 362 deaths have been reported to date. Airborne droplet and contact precautions are highly recommended. If you have respiratory symptoms and...

Post

Screen for Colon Cancer !

Colorectal Cancer Canada(CCC) states Colorectal Cancer (CRC) deaths are continuing to decline in Canada. This is likely due to improvements in treatment and diagnosis. The decline in CRC death rates are consistent with a relatively large contribution from screening and with a smaller impact of risk factor reductions. CRC develops from precancerous polyps. Screening tests...

Post

July 28, 2018 is World Hepatitis Day.

In Canada, 44% of people living with chronic HCV are unaware they have the disease, despite availability of screening and access to effective treatment. In 2017, there were 285 cases of HCV reported to Peel Public Health. Although many cases are initially asymptomatic, early diagnosis and treatment of HCV is important to decrease the risk...

Post

Increase in locally-acquired Cyclosporiasis in Ontario

https://www.canada.ca/en/public-health/services/diseases/cyclosporiasis-cyclospora/health-professionals-cyclosporiasis-cyclospora.html http://www.publichealthontario.ca/en/browsebytopic/infectiousdiseases/pages/IDlandingpages/cyclosporiasis.aspx Ontario has experienced 36 locally-acquired cyclosporiasis since April 1, 2018 until July 19, 2018. Cyclosporiasis is an infection of small bowel by parasite Cyclospora cayetanenis. Symptoms are: frequent, watery diarrhea; anorexia; fatigue; abdominal cramps; nausea; and myalgia. If untreated, symptoms last 6-7 weeks and vary in intensity. Cases are usually from travelers to endemic...

Post

Lyme Disease-Positive Ticks in Peel

Blacklegged ticks are the only ticks carrying Lyme disease bacteria so-called ‘Borrelia burgdorferi’ in Ontario. They are mostly active in early spring (April) and fall (October). Lyme is transmitted by both adult and immature ticks, nymphs. The characteristic rash of Lyme disease is called “erythema migrans” greater than 5cm with low-grade fever, fatigue, headache and...

Post

OHIP+: Children and Youth Pharmacare

  OHIP+ will provide drug coverage for children and youth who are covered by OHIP and aged 24 and under. OHIP+ begins January 1, 2018. http://www.health.gov.on.ca/en/pro/programs/drugs/ohipplus/

  • 1
  • 2